Imberti, Jacopo Francesco
 Distribuzione geografica
Continente #
NA - Nord America 8.193
AS - Asia 6.470
EU - Europa 3.068
SA - Sud America 969
OC - Oceania 256
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 129
Totale 19.247
Nazione #
US - Stati Uniti d'America 7.902
SG - Singapore 2.074
CN - Cina 1.921
IT - Italia 1.127
BR - Brasile 752
HK - Hong Kong 731
VN - Vietnam 616
GB - Regno Unito 379
FI - Finlandia 305
KR - Corea 299
DE - Germania 275
BD - Bangladesh 265
AU - Australia 254
SE - Svezia 229
RU - Federazione Russa 195
FR - Francia 142
CA - Canada 140
ID - Indonesia 102
IN - India 91
AR - Argentina 78
MX - Messico 76
NL - Olanda 74
JP - Giappone 43
AE - Emirati Arabi Uniti 40
IQ - Iraq 40
TR - Turchia 40
PL - Polonia 38
ZA - Sudafrica 38
AT - Austria 35
PK - Pakistan 35
CO - Colombia 33
UA - Ucraina 33
BG - Bulgaria 31
EC - Ecuador 31
ES - Italia 31
LT - Lituania 31
UZ - Uzbekistan 22
VE - Venezuela 22
CL - Cile 20
IE - Irlanda 20
MA - Marocco 20
EG - Egitto 19
MY - Malesia 17
TH - Thailandia 17
KE - Kenya 16
RS - Serbia 16
SA - Arabia Saudita 14
AZ - Azerbaigian 13
BE - Belgio 13
JM - Giamaica 13
RO - Romania 13
CR - Costa Rica 12
CZ - Repubblica Ceca 12
DZ - Algeria 11
PY - Paraguay 11
TW - Taiwan 11
TN - Tunisia 10
BO - Bolivia 9
GT - Guatemala 9
JO - Giordania 9
OM - Oman 9
KZ - Kazakistan 8
PH - Filippine 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
EE - Estonia 7
HU - Ungheria 7
NP - Nepal 7
PE - Perù 7
AL - Albania 6
CH - Svizzera 6
GE - Georgia 6
SV - El Salvador 6
CU - Cuba 5
DO - Repubblica Dominicana 5
IL - Israele 5
IR - Iran 5
UY - Uruguay 5
BY - Bielorussia 4
HN - Honduras 4
HR - Croazia 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
CY - Cipro 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NO - Norvegia 3
PS - Palestinian Territory 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
ET - Etiopia 2
GD - Grenada 2
GR - Grecia 2
Totale 19.057
Città #
Singapore 1.287
Ashburn 1.088
Santa Clara 1.021
Hefei 931
San Jose 893
Hong Kong 723
Council Bluffs 364
Seoul 299
Helsinki 246
Beijing 242
Fairfield 239
Los Angeles 222
Chandler 220
London 215
New York 211
Ho Chi Minh City 202
Nyköping 180
Perth 167
The Dalles 166
Hanoi 134
Dallas 126
Chicago 123
Milan 114
Houston 107
Woodbridge 97
Bologna 94
Munich 91
Seattle 91
Buffalo 89
Rome 79
Wilmington 79
Cambridge 72
Lauterbourg 71
São Paulo 71
Shanghai 70
Jakarta 69
Modena 62
Kent 52
Moscow 51
San Diego 50
Salt Lake City 49
Orem 41
Mexico City 40
Montreal 40
Sydney 40
Lappeenranta 39
Princeton 39
Boardman 38
Frankfurt am Main 36
Tokyo 35
Ann Arbor 34
Atlanta 33
Da Nang 33
Columbus 32
Toronto 32
Denver 29
Haiphong 29
Phoenix 29
Sofia 29
Warsaw 26
Belmont 25
Schiffdorf 25
Southend 25
Johannesburg 24
Nuremberg 24
Turin 24
Amsterdam 23
Brooklyn 23
Redondo Beach 23
Lakewood 22
Memphis 22
Dublin 20
Naples 20
San Francisco 20
Tashkent 20
Boston 19
Guangzhou 19
Rio de Janeiro 19
Turku 19
Vienna 19
Parma 18
Stockholm 18
Düsseldorf 17
Miami 17
North Bergen 17
Baghdad 16
Brasília 16
Lansdowne 16
Portsmouth 16
Tampa 16
Belo Horizonte 15
Campinas 15
Chennai 15
Hải Dương 15
Kilburn 15
Biên Hòa 14
Charlotte 14
Curitiba 14
Elk Grove Village 14
Melbourne 14
Totale 12.158
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 516
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) 350
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 330
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 316
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 297
Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing 296
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 293
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 292
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 275
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 267
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 253
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 248
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 245
Remote monitoring and telemedicine in heart failure: implementation and benefits 233
Progression of Atrial Fibrillation after Cryoablation 231
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 231
Atrial fibrillation burden: Stepping beyond the categorical characterization 228
Single-lead VDD pacing: a literature review on short-term and long-term performance 227
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 218
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 215
What do we do about atrial high rate episodes? 215
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 212
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 212
Clinical significance and prognostic value of right bundle branch block in permanent pacemaker patients 210
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 210
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 207
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 200
Female sex and stroke in atrial fibrillation: an intriguing relationship 199
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 197
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 193
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 190
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 188
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 188
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 186
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 186
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 184
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 184
Atrial fibrillation in pneumonia: what clinical implications at long-term? 182
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 179
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: A systematic review and meta-analysis 177
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 177
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 175
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 173
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 172
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 169
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 168
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 166
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 162
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 160
Clinical decisions for appropriate management of patients with atrial fibrillation 159
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 159
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 156
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 155
Inhibition of lysyl oxidase stimulates TGF-β signaling and metalloproteinases-2 and -9 expression and contributes to the disruption of ascending aorta in rats: protection by propylthiouracil 153
Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry 153
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 152
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 150
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 148
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 148
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation 147
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 146
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 144
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 141
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 141
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe 140
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 138
Echocardiographic Left Ventricular Mass Assessment: Correlation between 2D-Derived Linear Dimensions and 3-Dimensional Automated, Machine Learning-Based Methods in Unselected Patients 138
The epidemiology and mortality of patients with atrial fibrillation: a complex landscape 137
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 135
Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation 134
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 134
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation 132
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 132
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 131
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 131
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 128
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 126
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 125
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry 125
Antiarrhythmic drugs in the era of atrial fibrillation ablation 124
Access to implantable cardioverter defibrillator therapy within and across countries: the barriers still persist 123
Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations? 120
Mobile health technology in atrial fibrillation 120
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients 118
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 118
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 118
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke 117
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy 117
The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome 116
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex 113
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 112
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study" 109
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 107
Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology 107
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction 107
Length of hospital stay for elective electrophysiological procedures: a survey from the European Heart Rhythm Association 104
Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? 104
Remote monitoring of cardiac implantable electronic devices: from data to clinical actions 99
Atrial fibrillation screening: The importance of the patient perspective 98
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 95
Totale 17.566
Categoria #
all - tutte 87.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022525 0 0 0 24 25 43 18 38 68 42 126 141
2022/2023835 88 92 81 50 64 110 29 90 94 19 73 45
2023/20241.088 18 55 67 110 240 141 88 132 18 37 57 125
2024/20254.367 74 58 264 230 616 564 407 263 420 285 633 553
2025/20269.430 679 430 805 1.129 975 476 1.306 537 1.128 787 667 511
2026/20272.282 516 595 744 427 0 0 0 0 0 0 0 0
Totale 19.247